EU endocrine disruptors strategy takes a step forward

The EU strategy on endocrine-disrupting chemicals has taken a step forward with the release of two research studies reviewing chemicals on the European Commission's list of potential endocrine disruptors. Of nine industrial compounds reviewed in detail, only one instance of endocrine-disrupting effects was highlighted -thyroid disruption by resorcinol. But a wide-ranging study highlighted 93 more compounds of "exposure concern".

Sign in to continue

Sign in

Trouble signing in?

Reset password: Click here

Email: report@ends.co.uk

Call: 020 8267 8120

Register for
Free Trial

  • 14 day access to subscriber-only content

Register

Subscribe

Prices on request

  • Full access to endsreport.com for 12 months
  • Monthly print issues
  • Clear and accessible guidance on relevant legislation
  • Integration with ENDS Compliance Manager helping you plan ahead and ensure compliance for your organisation
  • Individual or bespoke multi-user packages available

See all benefits